2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theNeurological Biomarkers Market?

Rising incidences of disorders related to the nervous system are anticipated to boost the growth of the neurological biomarker market. Neurological conditions have an impact on the brain, spinal cord, and the rest of the body’s nerves. Parkinson’s disease is a degenerative neurological condition influencing the nervous system and the regions of the body controlled by the nerves. Neurological biomarkers aid in detecting Parkinson’s disease at an early stage through pathological, biochemical, and genetic examinations. For example, Parkinson’s Foundation, a non-profit organization based in the US, reported in December 2022 that the count of new Parkinson’s disease diagnoses had spiked to 90,000 in 2022 from 60,000 annually in 2021. Thus, the escalating prevalence of neurological disorders is spurring the expansion of the neurological biomarker market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp

#What is the Projected CAGR for the Neurological Biomarkers Market Size from 2025 to 2034?

Over the past few years, the size of the neurological biomarkers market has seen a significant expansion. It’s projected to increase from a market size of $10.7 billion in 2024 to $11.96 billion in 2025, displaying a compound annual growth rate (CAGR) of 11.7%. Factors such as the rising instances of neurological disorders, an aging demographic, the demands of drug development, larger funds dedicated to neurological research, and personalized medicine are chiefly attributed to the growth during the historic period.

In the coming years, the neurologic biomarkers market is projected to experience swift expansion. Predictions suggest it will reach $19.96 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.7%. This anticipated growth in the forecast period can be linked to early detection biomarkers, wearable tech, biosensors, global health programs, and a patient-focused strategy. Future market trends are expected to involve innovations in imaging technology, rapid progress in omics technologies, the application of artificial intelligence, real-world evidence for biomarker validation, tech advancements in diagnostics, and cross-industry collaboration with research institutes.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12677

What Are the Latest Innovations Influencing theNeurological Biomarkers Market?

Major players in the neurological biomarkers market are joining forces to create new products and enhance their market standings. Such collaborations and partnerships stimulate innovation, encourage the sharing of unique specializations, and fast-track the creation and marketing of novel therapies by pooling resources and skills. For example, in July 2022, NeuroSense Therapeutics Ltd., a company from Israel that focuses on creating therapies for severe neurodegenerative ailments, partnered with NeuraLight, another Israel-based company that is working on reliable and sensitive biomarkers for neurological issues. The aim of this partnership is to use AI (Artificial Intelligence) and ML (Machine Learning) to identify oculometric indicators for Amyotrophic Lateral Sclerosis (ALS). This partnership, which follows NeuraLight’s Series A funding of $25 million, aims to improve the detection and usage of digital ALS indicators in a simultaneous study – their debut clinical trial. At the heart of this partnership is the use of these oculometric digital indicators which could potentially enable patient sorting and increase successful outcomes in clinical trials.

Who Are the Major Industry Players Accelerating Growth in theNeurological Biomarkers Market?

Major companies operating in the neurological biomarkers market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, Acumen Pharmaceuticals.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

Which Primary Segments of the Neurological Biomarkers Market Are Driving Growth and Industry Transformations?

The neurological biomarkers market covered in this report is segmented –

1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

Subsegments:

1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers

2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers

3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers

4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers

5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12677&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theNeurological Biomarkers Market?# Market?

North America was the largest region in the neurological biomarkers market in 2024. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Neurological Biomarkers Maret 2025, By The Business Research Company:

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Neurology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Renal Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: